Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588120 · ClinicalTrials.gov registry record · Phase 1
Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 114
- Enrollment target
NCT00588120: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT00588120 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 114 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588120, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about a condition called 'unclassified hyperoxaluria'. People with this condition have large amounts of oxalate in their urine, which can cause kidney stones and kidney failure. We do not know what causes the high level of oxalate in the urine. In this study, we will evaluate absorption of a test dose of oxalate taken orally by measuring the amount of the test dose that is eliminated in the urine. We will compare the results of affected patients to healthy volunteers.
Interventions
- DRUG C-13 labeled oxalate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 1998-12 |
| Est. Completion | 2020-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588120
The ClinicalTrials.gov registry entry for NCT00588120 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which C-13 labeled oxalate is the first listed.
NCT00588120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588120 about?
NCT00588120 is a clinical study titled "Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria". The purpose of this study is to learn more about a condition called 'unclassified hyperoxaluria'. People with this condition have large amounts of oxalate in their urine, which can cause kidney stones and kidney failure. We do not know what causes the high level of oxalate in the urine. In this stud...
What is the current status of trial NCT00588120?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 114 participants. The study started on 1998-12. Estimated completion is 2020-01.
What interventions are being tested in trial NCT00588120?
The interventions under investigation include: C-13 labeled oxalate (DRUG).
Who is sponsoring clinical trial NCT00588120?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.